Reversibility of platelet P2Y12 inhibition by platelet supplementation:ex vivoandin vitrocomparisons of prasugrel, clopidogrel and ticagrelor-Reference-Cited by-同舟云学术

Reversibility of platelet P2Y12 inhibition by platelet supplementation:ex vivoandin vitrocomparisons of prasugrel, clopidogrel and ticagrelor

Published:2018-04-23 Issue:6 Volume:16 Page:1089-1098
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Bertling A.¹²,Fender A. C.¹²³,Schüngel L.¹²,Rumpf M.¹²,Mergemeier K.¹²,Geißler G.⁴,Sibrowski W.⁴,Kelsch R.⁴,Waltenberger J.⁵,Jakubowski J. A.⁶,Kehrel B. E.¹²

Affiliation:

1. Department of Anaesthesiology Intensive Care and Pain Medicine University Hospital Muenster Muenster Germany

2. Experimental and Clinical Haemostasis University Hospital Muenster MuensterGermany

3. Institute of Pharmacology University Hospital Essen EssenGermany

4. Institute of Transfusion Medicine University Hospital MuensterMuenster Germany

5. Department of Cardiovascular Medicine University Hospital Muenster Muenster Germany

6. Lilly Research Laboratories Eli Lilly and Company Indianapolis IN USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14014

Reference26 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. Long‐term use of ticagrelor in patients with prior myocardial infarction;Bonaca MP;N Engl J Med,2015

3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

4. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

5. Emergency Reversal of Clopidogrel in the Setting of Spontaneous Intracerebral Hemorrhage

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024;The Journal of Heart and Lung Transplantation;2024-10

2. ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events;European Heart Journal Supplements;2024-04

3. G protein-coupled P2Y12 receptor is involved in the progression of neuropathic pain;Biomedicine & Pharmacotherapy;2023-06

4. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding;European Heart Journal;2023-03-29

5. The role and pharmacological properties of P2Y12 receptor in cancer and cancer pain;Biomedicine & Pharmacotherapy;2023-01